Brimica genuair 340 micrograms 12 micrograms inhalation. Consult smpc and package leaflet for method of administration. Brimica genuair est indique comme traitement bronchodilatateur continu pour soulager les symptomes. The genuair inhaler is a new multidose dry powder inhaler for the delivery of aclidinium bromide a novel, longacting, muscarinic antagonist in development for the treatment of chronic obstructive pulmonary disease copd. Brimica genuair 340 microgrammes12 microgrammes poudre pour inhalation. The primary aim of this study was to assess the inspiratory flow characteristics through genuair in patients with moderate or severe copd. Product subject to medical prescription which may be renewed b updated on 27 june 2018. Brimica genuair 340 micrograms 12 micrograms inhalation powder. Approval received for eklira genuair, a treatment for copd. It is administered using the genuair inhalation device, a preloaded and ready to use multidose powder inhaler. Bretaris genuair et ekliragenuair ont lamm comme traitement bronchodilatateur. Approval received for eklira genuair, a treatment for copd pdf 121. Eklira genuair 322 micrograms inhalation powder medicines.
Eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease copd. These highlights do not include all the information needed to use duaklir pressair. Release of eklira genuair, a treatment for copdnews. Aclidinium bromide, a selective longacting, smallmolecule muscarinic m3 receptor antagonist lama, is being developed by astrazeneca for the maintenance. Eklira genuair is an aclidinium bromidebased proprietary medicinal product, a new longacting anticholinergic, indicated as a maintenance bronchodilator treatment for copd. Summary of product characteristics last updated on medicines.
Tudorza genuair aclidinium bromide dry powder for oral inhalation. You can help by reporting any side effects you may get. What you need to know before you use eklira genuair. Since preclinical studies indicated that both acl and gly may have a faster onset of action than tio, we investigated the real differences in onset of. Onset of action of aclidinium acl, glycopyrronium gly. Release of eklira genuair, a treatment for copd pdf 192. Peak inspiratory flow through the genuair inhaler in. This will allow quick identification of new safety information. Eklira genuair 322 microgrammes poudre pour inhalation. Brimica genuair 34012 micrograms inhalation powder. See the end of section 4 for how to report side effects.
8 556 1076 212 569 940 34 1392 332 194 1 483 1092 150 62 603 1296 1440 406 76 158 1022 887 138 1376 1109 101 832 1405 727 734 1297